Home/Pipeline/RWE Data Pipeline

RWE Data Pipeline

Oncology (Broad)

CommercialActive

Key Facts

Indication

Oncology (Broad)

Phase

Commercial

Status

Active

Company

Perthera

About Perthera

Perthera is a leader in AI-driven precision oncology, offering a comprehensive platform that integrates multi-omic testing results and patient history to match cancer patients with ranked therapy options. Its core product, the Perthera Report®, is used by oncologists to optimize treatment decisions and streamline clinical workflows, while its data pipeline supports real-world evidence generation and clinical trial matching. The company has established a significant footprint, with its platform reportedly used in 600 hospitals/clinics and by 10% of US medical oncologists, and it demonstrates strong clinical impact metrics, including a 2.4x improvement in progression-free survival for its patients.

View full company profile

Therapeutic Areas

Oncology

Other Oncology (Broad) Drugs

Drug	Company	Phase	Status
Functional Precision Oncology Platform Validation	Known Medicine	Pre-clinical	Active
Clinical Trial Program	VitroScan	N/A (Diagnostic Validation)	Active
Personalized Treatment Screening	Okomera	Pre-clinical	Active
Preclinical Drug Discovery Services	Okomera	Pre-clinical	Active
Clinical Trial Matching Service	Perthera	Commercial	Active
Enhanced Liquid Biopsy Platform	Wobble Genomics	Platform Validation	Active
Live Tissue Biobanking Service	SpeciCare	Service	Active
Ex Vivo Therapy Testing	SpeciCare	Research	Active
Personalized Vaccine Support	SpeciCare	Research	Active
Clinical Trial Matching & Access	SpeciCare	Service	Active
Organoid Creation & Biobanking	SpeciCare	Research	Active